BIOBUSINESS Regulatory Updates news from GENTracks compounds through various phases of FDA applications and approvals through to patent issuance. Thursday, March 13, 2008http://www.genengnews.com/news/newslist.aspx?taxid=7 Hawthorn Pharmaceuticals, Inc. Receives FDA Approval on Granisol(TM) Oral Solution Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32009328 Lev Announces FDA's Blood Products Advisory Committee to Review Cinryze (TM) (C1 inhibitor) Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32000260 Calando Files IND for siRNA Nanoparticle Therapeutic in Oncology Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31997828 No Sign of ANDA Filing for Daptomycin Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31992938 Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31991316 Raven biotechnologies Advances RAV18 Through Agreement With CMC ICOS Biologics Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31943502 FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31941937